Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A cell-free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs

E. Filová, M. Rampichová, A. Litvinec, M. Držík, A. Míčková, M. Buzgo, E. Košťáková, L. Martinová, D. Usvald, E. Prosecká, J. Uhlík, J. Motlík, L. Vajner, E. Amler,

. 2013 ; 447 (1-2) : 139-149.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT12156 MZ0 CEP Register

The aim of the study was to evaluate the effect of a cell-free hyaluronate/type I collagen/fibrin composite scaffold containing polyvinyl alcohol (PVA) nanofibers enriched with liposomes, basic fibroblast growth factor (bFGF) and insulin on the regeneration of osteochondral defects. A novel drug delivery system was developed on the basis of the intake effect of liposomes encapsulated in PVA nanofibers. Time-controlled release of insulin and bFGF improved MSC viability in vitro. Nanofibers functionalized with liposomes also improved the mechanical characteristics of the composite gel scaffold. In addition, time-controlled release of insulin and bFGF stimulated MSC recruitment from bone marrow in vivo. Cell-free composite scaffolds containing PVA nanofibers enriched with liposomes, bFGF, and insulin were implanted into seven osteochondral defects of miniature pigs. Control defects were left untreated. After 12 weeks, the composite scaffold had enhanced osteochondral regeneration towards hyaline cartilage and/or fibrocartilage compared with untreated defects that were filled predominantly with fibrous tissue. The cell-free composite scaffold containing PVA nanofibers, liposomes and growth factors enhanced migration of the cells into the defect, and their differentiation into chondrocytes; the scaffold was able to enhance the regeneration of osteochondral defects in minipigs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031535
003      
CZ-PrNML
005      
20191021094853.0
007      
ta
008      
131002s2013 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2013.02.056 $2 doi
035    __
$a (PubMed)23499757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Filová, Eva $u Institute of Experimental Medicine of the ASCR, Vídenská 1083, 142 20 Prague, Czech Republic. evafil@biomed.cas.cz $7 xx0171464
245    12
$a A cell-free nanofiber composite scaffold regenerated osteochondral defects in miniature pigs / $c E. Filová, M. Rampichová, A. Litvinec, M. Držík, A. Míčková, M. Buzgo, E. Košťáková, L. Martinová, D. Usvald, E. Prosecká, J. Uhlík, J. Motlík, L. Vajner, E. Amler,
520    9_
$a The aim of the study was to evaluate the effect of a cell-free hyaluronate/type I collagen/fibrin composite scaffold containing polyvinyl alcohol (PVA) nanofibers enriched with liposomes, basic fibroblast growth factor (bFGF) and insulin on the regeneration of osteochondral defects. A novel drug delivery system was developed on the basis of the intake effect of liposomes encapsulated in PVA nanofibers. Time-controlled release of insulin and bFGF improved MSC viability in vitro. Nanofibers functionalized with liposomes also improved the mechanical characteristics of the composite gel scaffold. In addition, time-controlled release of insulin and bFGF stimulated MSC recruitment from bone marrow in vivo. Cell-free composite scaffolds containing PVA nanofibers enriched with liposomes, bFGF, and insulin were implanted into seven osteochondral defects of miniature pigs. Control defects were left untreated. After 12 weeks, the composite scaffold had enhanced osteochondral regeneration towards hyaline cartilage and/or fibrocartilage compared with untreated defects that were filled predominantly with fibrous tissue. The cell-free composite scaffold containing PVA nanofibers, liposomes and growth factors enhanced migration of the cells into the defect, and their differentiation into chondrocytes; the scaffold was able to enhance the regeneration of osteochondral defects in minipigs.
650    _2
$a zvířata $7 D000818
650    _2
$a buňky kostní dřeně $x cytologie $7 D001854
650    12
$a regenerace kostí $7 D001861
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a viabilita buněk $7 D002470
650    _2
$a chondrocyty $x cytologie $7 D019902
650    _2
$a kolagen typu I $x chemie $7 D024042
650    _2
$a modul pružnosti $7 D055119
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrin $x chemie $7 D005337
650    _2
$a fibroblastový růstový faktor 2 $x aplikace a dávkování $7 D016222
650    _2
$a kyselina hyaluronová $x chemie $7 D006820
650    _2
$a inzulin $x aplikace a dávkování $7 D007328
650    _2
$a liposomy $7 D008081
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mezenchymální kmenové buňky $x cytologie $7 D059630
650    _2
$a nanovlákna $x aplikace a dávkování $x chemie $7 D057139
650    _2
$a polyvinylalkohol $x chemie $7 D011142
650    _2
$a prasata $7 D013552
650    _2
$a miniaturní prasata $7 D013556
650    _2
$a tkáňové podpůrné struktury $7 D054457
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rampichová, Michala $u - $7 xx0171325
700    1_
$a Litvinec, Andrej $u - $7 xx0239124
700    1_
$a Držík, Milan $u -
700    1_
$a Míčková, Andrea $u -
700    1_
$a Buzgo, Matej $u - $7 xx0255533
700    1_
$a Kuželová Košťáková, Eva $u - $7 xx0073449
700    1_
$a Martinová, Lenka $u -
700    1_
$a Usvald, Dušan $u - $7 xx0110082
700    1_
$a Prosecká, Eva $u - $7 xx0171465
700    1_
$a Uhlík, Jiří, $u - $d 1966- $7 jn20010309782
700    1_
$a Motlík, Jan, $u - $d 1946- $7 ola200208047
700    1_
$a Vajner, Luděk, $d 1954- $7 jn20010309783
700    1_
$a Amler, Evžen, $u - $d 1958- $7 xx0014074
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 447, č. 1-2 (2013), s. 139-149
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23499757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20191021095326 $b ABA008
999    __
$a ok $b bmc $g 995622 $s 829980
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 447 $c 1-2 $d 139-149 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
GRA    __
$a NT12156 $p MZ0
LZP    __
$a Pubmed-20131002

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...